Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
State of the Art in Microrna As Diagnostic and Therapeutic Biomarkers in Chronic Lymphocytic Leukemia Publisher Pubmed



Mirzaei H1 ; Fathullahzadeh S2 ; Khanmohammadi R3 ; Darijani M4 ; Momeni F5 ; Masoudifar A6 ; Goodarzi M7 ; Mardanshah O8 ; Stenvang J9 ; Jaafari MR10 ; Mirzaei HR11
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Medical Biotechnology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. Medical Biotechnology Research Center, Ashkezar Branch, Islamic Azad University, Ashkezar, Yazd, Iran
  3. 3. Department of pediatric dentistry, School of dentistry, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Department of Oral and Maxillofacial Radiology, School of Dentistry, Kerman University of Medical Sciences, Kerman, Iran
  5. 5. Applied Physiology Research Center, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran
  6. 6. Department of Molecular Biotechnology, Cell Science Research Center, Royan Institute for Biotechnology, ACECR, Isfahan, Iran
  7. 7. Faculty of Bioscience Engineering, Department of Biosystems, Katholieke Universiteit Leuven – KULeuven, Heverlee, Belgium
  8. 8. Department of Parasitology and Mycology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
  9. 9. Faculty of Health and Medical Sciences, Section for Molecular Disease Biology, Department of Veterinary Disease Biology, University of Copenhagen, Copenhagen, Denmark
  10. 10. Nanotechnology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  11. 11. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Cellular Physiology Published:2018


Abstract

Early diagnostic is one of the most important steps in cancer therapy which helps to design and choose a better therapeutic approach. The finding of biomarkers in various levels including genomics, transcriptomics, and proteomics levels could provide better treatment for various cancers such as chronic lymphocytic leukemia (CLL). The CLL is the one of main lymphoid malignancies which is specified by aggregation of mature B lymphocytes. Among different biomarkers (e.g., CD38, chromosomes abnormalities, ZAP-70, TP53, and microRNA [miRNA]), miRNAs have appeared as new diagnostic and therapeutic biomarkers in patients with the CLL disease. Multiple lines of evidence indicated that deregulation of miRNAs could be associated with pathological events which are present in the CLL. These molecules have an effect on a variety of targets such as Bcl2, c-fos, c-Myc, TP53, TCL1, and STAT3 which play critical roles in the CLL pathogenesis. It has been shown that expression of miRNAs could lead to the activation of B cells and B cell antigen receptor (BCR). Moreover, exosomes containing miRNAs are one of the other molecules which could contribute to BCR stimulation and progression of CLL cells. Hence, miRNAs and exosomes released from CLL cells could be used as potential diagnostic and therapeutic biomarkers for CLL. This critical review focuses on a very important aspect of CLL based on biomarker discovery covers the pros and cons of using miRNAs as important diagnostics and therapeutics biomarkers for this deadly disease. © 2017 Wiley Periodicals, Inc.
Related Docs
View other Related Docs
1. Role of Micrornas in Chronic Lymphocytic Leukemia Pathogenesis, Current Medicinal Chemistry (2020)
2. Microrna in Leukemia: Tumor Suppressors and Oncogenes With Prognostic Potential, Journal of Cellular Physiology (2019)
3. Exosomes and Micrornas: New Potential Therapeutic Candidates in Alzheimer Disease Therapy, Journal of Cellular Physiology (2019)
4. Tumor-Associated Macrophages and Epithelial–Mesenchymal Transition in Cancer: Nanotechnology Comes Into View, Journal of Cellular Physiology (2018)
5. Micro-Rnas As Critical Regulators of Matrix Metalloproteinases in Cancer, Journal of Cellular Biochemistry (2018)
6. Mesenchymal Stem Cells: A New Platform for Targeting Suicide Genes in Cancer, Journal of Cellular Physiology (2018)
7. Micrornas-Based Imaging Techniques in Cancer Diagnosis and Therapy, Journal of Cellular Biochemistry (2017)
8. Microrna: A Novel Target of Curcumin in Cancer Therapy, Journal of Cellular Physiology (2018)
Experts (# of related papers)
View all Related Experts
Hamid Reza Mirzaei (13)
Babak Negahdari (4)
Other Related Docs
9. Micrornas and Exosomes in Depression: Potential Diagnostic Biomarkers, Journal of Cellular Biochemistry (2018)
10. Influenza Vaccine: Where Are We and Where Do We Go?, Reviews in Medical Virology (2019)
11. Microrna: Relevance to Stroke Diagnosis, Prognosis, and Therapy, Journal of Cellular Physiology (2018)
12. Mirna-Based Strategy for Modulation of Influenza a Virus Infection, Epigenomics (2018)
13. Teeth-Derived Stem Cells: A Source for Cell Therapy, Journal of Cellular Physiology (2019)
14. Cancer Stem Cells and Oral Cancer: Insights Into Molecular Mechanisms and Therapeutic Approaches, Cancer Cell International (2020)
15. Therapeutic Application of Multipotent Stem Cells, Journal of Cellular Physiology (2018)
16. Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?, Journal of Cellular Physiology (2017)
17. Identification of Mir-125A As a Novel Plasma Diagnostic Biomarker for Chronic Lymphoblastic Leukemia, Clinical Laboratory (2019)
18. Circulating Micrornas As Diagnostic and Therapeutic Biomarkers in Gastric and Esophageal Cancers, Journal of Cellular Physiology (2018)
19. Nanoparticles As New Tools for Inhibition of Cancer Angiogenesis, Journal of Cellular Physiology (2018)
20. Oral Tumors in Children: Diagnosis and Management, Journal of Cellular Biochemistry (2018)
21. Exosome Application in Treatment and Diagnosis of B-Cell Disorders: Leukemias, Multiple Sclerosis, and Arthritis Rheumatoid, Cellular and Molecular Biology Letters (2022)
22. Micrornas and Exosomes: Cardiac Stem Cells in Heart Diseases, Pathology Research and Practice (2022)
23. Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases, Journal of Cellular Biochemistry (2018)
24. Glioblastoma: Exosome and Microrna As Novel Diagnosis Biomarkers, Cancer Gene Therapy (2016)
25. Predictive and Therapeutic Biomarkers in Chimeric Antigen Receptor T-Cell Therapy: A Clinical Perspective, Journal of Cellular Physiology (2019)
26. Design, Expression and Evaluation of Novel Chimeric Protein Constructed From Colorectal Tumor-Associated Antigen, Journal of Cellular Biochemistry (2018)
27. Imaging Techniques: New Avenues in Cancer Gene and Cell Therapy, Cancer Gene Therapy (2017)
28. Circulating Microrna: A New Candidate for Diagnostic Biomarker in Neuroblastoma, Cancer Gene Therapy (2016)
29. Apoptotic Effect of Berberine Via Bcl-2, Ror1, and Mir-21 in Patients With B-Chronic Lymphocytic Leukemia, Phytotherapy Research (2021)
30. Non-Coding Rnas in Leukemia Drug Resistance: New Perspectives on Molecular Mechanisms and Signaling Pathways, Annals of Hematology (2024)
31. Anoikis Resistance and Oncoviruses, Journal of Cellular Biochemistry (2018)
32. Recent Advances in the Roles of Exosomal Micrornas (Exomirs) In Hematologic Neoplasms: Pathogenesis, Diagnosis, and Treatment, Cell Communication and Signaling (2023)
33. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
34. Pathogenic Role of Exosomes and Micrornas in Hpv-Mediated Inflammation and Cervical Cancer: A Review, International Journal of Cancer (2020)
35. A Review on Leukemia and Ipsc Technology: Application in Novel Treatment and Future, Current Stem Cell Research and Therapy (2018)
36. Curcumin: A New Candidate for Melanoma Therapy?, International Journal of Cancer (2016)
37. The Promising Role of Non-Coding Rnas As Biomarkers and Therapeutic Targets for Leukemia, Genes (2023)
38. Immune Checkpoints and Ncrnas: Pioneering Immunotherapy Approaches for Hematological Malignancies, Cancer Cell International (2024)
39. Immunologic Balance of Regulatory T Cell/T Helper 17 Responses in Gastrointestinal Infectious Diseases: Role of Mirnas, Microbial Pathogenesis (2019)
40. Regulation of Tumor Angiogenesis by Micrornas: State of the Art, Journal of Cellular Physiology (2019)
41. Decreased Expression of Hsa-Mir-142-3P and Hsa-Mir-155-5P in Common Variable Immunodeficiency and Involvement of Their Target Genes and Biological Pathways, Allergologia et Immunopathologia (2025)
42. Sleep Disturbance and Gastrointestinal Cancer Risk: A Literature Review, Journal of Investigative Medicine (2023)
43. Differential Expression of Micrornas in Renal Transplant Patients With Acute T-Cell Mediated Rejection, Transplant Immunology (2015)
44. Role of Resveratrol in Modulating Micrornas in Human Diseases: From Cancer to Inflammatory Disorder, Current Medicinal Chemistry (2021)
45. The Role of Micrornas in Respiratory Viral Infection: Friend or Foe?, Reviews in Medical Virology (2016)
46. Dysregulated Expression of Tim-3 and Nkp30 Receptors on Nk Cells of Patients With Chronic Lymphocytic Leukemia, Oncology Research and Treatment (2019)
47. The Effect of Thymoquinone on Peripheral Blood Mononuclear Cells (Pbmcs) Viability of Patients With B-Chronic Lymphocytic Leukemia, Koomesh (2023)
48. Current Approaches in Identification and Isolation of Cancer Stem Cells, Journal of Cellular Physiology (2019)
49. Curcumin and Its Novel Formulations for the Treatment of Hepatocellular Carcinoma: New Trends and Future Perspectives in Cancer Therapy, Journal of Functional Foods (2023)
50. Prostate Cancer and Noncoding Rnas: A Focus on Mirnas, Lncrnas, and Circrnas, Prostate Cancer: Molecular Events and Therapeutic Modalities (2024)